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Background. Superantigens and eicosanoids are important amplifiers and regulators of inflammation in airway
diseases. We therefore studied the possible influence of Staphylococcus aureus enterotoxin B (SEB) on the cyclooxy-
genase (COX) pathway and basic functions of airway structural cells.
Methods. Fibroblasts were isolated from nasal inferior turbinate tissue and cultured in the presence of different
concentrations of SEB. Preincubation with interferon (IFN)– was performed to induce expression of major histo-
compatibility complex (MHC) class II receptors. Prostaglandin E2 (PGE2) production was assayed by enzyme-linked
immunosorbent assay, and levels of COX-2 and prostanoid E receptors 1–4 (EP1–4) were assayed by real-time poly-
merase chain reaction.Migration and growth tests were performed, and SEBwas localized within the cells by confocal
microscopy.
Results. Stimulationwith IFN- and SEB significantly down-regulated PGE2, COX-2, and EP2 expression but not
EP1, EP3, or EP4 expression. The enterotoxin blocked cell growth but increased the fibroblast migration rate. SEB was
localized within the cell in the presence and absence ofMHC-II, suggesting that mechanisms other than conventional
binding may allow the enterotoxin to enter the cell.
Conclusions. These findings may have major implications for our understanding of the role played by bacterial
superantigens in regulating the inflammatory and remodeling mechanisms of upper airway diseases and hence may
help elucidate the pathophysiology of these diseases.
Fibroblasts are important sentinel cells of the immune
system, playing a critical role in chronic inflammation
and tissue repair. However, the implication of these cells
in the regulation of immune responses has long been
neglected. Recently, several studies have demonstrated
that human lung fibroblasts activated through the
CD40-CD40L bridge may up-regulate prostaglandin E2
(PGE2) production [1] and, hence, hematopoietic cells
infiltration in damaged tissue [2]. This interaction acti-
vates the transcription factor NF-B, resulting in the
synthesis of high levels of cytokine mediators (e.g., in-
terleukin [IL]–6 and IL-8), adhesionmolecules (e.g., in-
tercellular and vascular cell adhesion molecules), and
cyclooxygenase (COX) metabolites [3]. In the airways,
fibroblasts play a crucial role in the remodeling process.
These cells are a primary cellular source of collagens and
growth factors, which play a crucial role in epithelial
regeneration and tissue remodeling processes [4].
The potential role played by superantigens in the
pathogenesis of airway diseases has become a relevant
issue during the last years [5]. Furthermore, it is
known that prostanoids, metabolites of arachidonic
acid, are crucial molecules in the control of inflam-
matory and remodeling processes in airways [6, 7].
We have previously demonstrated that immune re-
sponse to Staphylococcus aureus, in terms of IgE spe-
cific to S. aureus enterotoxins, correlates with total
IgE levels and severity of inflammation in patients
with nasal polyposis [8, 9]. Additionally, this immune
response to S. aureus enterotoxins was associated with
an amplification of the eosinophilic inflammation
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and an up-regulation of leukotrienes and lipoxins within na-
sal polyp tissue [9], which is also characterized by reduced
PGE2 concentrations [7].
Additionally, in vitro experiments have shown that S. aureus
enterotoxins can regulate the secretion of interstitial collagenase
and stromelysin in human fibroblastlike synoviocytes [10, 11],
and these cells can function as accessory cells for enterotoxin-
mediated T cell activation [12]. More recently, it was demon-
strated that S. aureus enterotoxins can induce IL-6 and IL-8 gene
expression on human fibroblastlike synoviocytes isolated from
patients with rheumatoid arthritis [13]. Production of PGE2 can
also be enhanced by these superantigens in bovinemononuclear
cells [14]. Until now there have been no studies regarding the
role played by S. aureus superantigens on structural cells from
the upper airways. Given the previous findings, we aimed to
study the capacity of S. aureus enterotoxin B (SEB) in regulating
the COX pathway and vital cell processes, such as growth and
migration, in nasal tissue fibroblasts.
MATERIALS AND METHODS
Samples. Fibroblasts were isolated from inferior turbinate tis-
sue obtained from patients (n  5) who were undergoing sep-
toplasty or rhinoseptoplasty because of anatomical variations
and were not suffering from any sinus disease. Surgery was per-
formed in the Department of Othorinolaryngology at Ghent
University Hospital. All patients gave informed consent before
their participation, and the study was approved by the ethical
committee of Ghent University Hospital.
Reagents. Dulbecco’s PBS, penicillin-streptomycin (peni-
cillin, 5000 IU/mL; streptomycin, 5000g/mL), and trypan blue
(0.4% solution in PBS) were obtained from Invitrogen. Mini-
mum essential medium (MEM), Opti-MEM I reduced serum
medium, L-glutamine (200 mmol/L), trypsin-EDTA (1), and
fetal bovine serum (FBS) (qualified; origin, United States) were
purchased fromGibco (Life Technologies). Ultroser G (5%)was
obtained from Biospera. Recombinant human interferon
(IFN)– was obtained from R&D Systems, and SEB was ob-
tained from Sigma Chemicals. SYBR Green I Master mix, Au-
rum Total RNA, and Script cDNA synthesis kits were obtained
from Bio-Rad Laboratories.
Fibroblast isolation from nasal tissue. Nasal tissues ob-
tained during surgical operations were rinsed several times with
Opti-MEM I supplemented with 5% FBS, 5% Ultroser G, 2
mmol/L glutamine, and penicillin (50 IU/mL)–streptomycin
(50 g/mL) and cut into small pieces (1 mm2). Diced speci-
mens were then plated (density, 9 pieces/6-well tissue culture
dish) and incubated in a humidified atmosphere containing 5%
CO2 at 37°C, until a monolayer of fibroblastlike cells was ob-
served to be confluent. Then the explanted tissues were re-
moved, and cells were trypsinized and replated into 250-cm2
tissue culture Falcon tubes at a final volume of 5 mL. The me-
dium was changed every 3 days for 2–3 weeks until 90% conflu-
ence was obtained. Subsequently, the cells were split and pas-
saged.
Cell stimulation. Cells were stimulated with 0.01, 0.1, or 1
g/mL SEB or 10 ng/mL IL-1 for 24 h at 37°C in 5% CO2. To
induce receptors for major histocompatibility complex (MHC)
class II, cells were pretreated with IFN- (10 ng/mL) for 24 h at
37°C in 5% CO2 and were then stimulated with 0.01, 0.1, or 1
g/mL SEB for 24 h at 37°C and 5% CO2. For each sample in
each experiment, we used a negative control that consisted of
cells incubated only with culture medium (MEM).
The cells were characterized with antibodies against vimen-
tine, cytokeratin, and –smooth muscle actin, using the
peroxidase–anti-peroxidase technique. Stimulated cell cultures
were centrifuged at 4°C, and the supernatants were collected and
stored at20°C until use. Subsequently, cells were trypsinized,
washed, resuspended in Opti-MEM I, and then centrifuged. Af-
ter the supernatants were removed, a portion of the cells were
resuspended in lysis buffer for posterior RNA extraction, and
another portion was stored at80°C.
Enzymatic immunoassays. Concentration of PGE2 were
measured by ELISAs in cell culture supernatants according to
the manufacturer’s instructions (Oxford Biomedical); the intra-
and interassay coefficient of variation for all ELISAs was10%.
Quantitative real-time polymerase chain reaction (PCR).
Cell cultures were centrifuged, and pellets containing 1  106 cells
were disrupted and homogenized in lysis solution. Total RNA
was extracted using the Aurum Total RNAMini Kit, and cDNA
was synthesized from 1g of RNA using the Script cDNAKit, in
accordance with the manufacturer’s instructions. Amplification
reactions were performed with the iCycler iQ Real-Time PCR
Detection System, with the specific primer sets (table 1). PCRs
included 20 ng of cDNA from cultured cells, 1 SYBR Green I
Master mix, and 300 nmol/L each primer. The PCR protocol
consisted of 1 cycle at 95°C for 10 min followed by 40 cycles at
95°C for 30 s and at 62°C for 1 min. Ubiquitin C and hypoxan-
thine phosphoribosyltransferase 1 were used as internal control
genes for normalization. Primer sequences for these genes were
obtained from the Real-Time PCR Primer and Probe Database
of the Department of Medical Genetics, University of Ghent
(http://medgen.ugent.be/rtprimerdb). The relative number of
molecules for each gene was expressed in relative expression
units quantified per 20 ng of cDNA sample and was determined
by the Ct value method.
Cell growth assay. Confluent cells in 25-cm2 Falcon dishes
were trypsinizedwith preheated trypsin-EDTA and resuspended
in 5 mL of Opti-MEM I. Living cells were counted with a
Neubauer counting chamber, seeded (10,000 cells/well) in a 24-
well plate, and incubated with Opti-MEM I, IFN- (10 ng/mL),
or SEB (0.1 g/mL) at 37°C and 5% CO2 for 24, 48, and 72 h. At
each time point, cells were again trypsinized with preheated
trypsin-EDTA and resuspended in 1mL ofOpti-MEM I, and the
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number of living cells at each time point was quantified with
trypan blue using the Neubauer counting chamber.
Cell migration assay. Fibroblasts were seeded in a 35-mm-
diameter 6-well plate, incubated at 1  105 cells/well in serum-
freeMEM, and allowed to growuntil confluency for 7 days. Then
the medium was replaced by 1Dulbecco’s PBS, and cells were
incubated at 37°C in 5% CO2 for 5 min. The monolayer was
wounded by pressing a sterile razor blade down onto the well,
making a sharp visible demarcation at the wound edge. The
blade was then gently moved to one side to remove a part of the
cellmonolayer. Two separated 15–20-mmwoundsweremade in
the same well. The wounded layers were washed 2 times with
Opti-MEM to remove the cell debris and incubated with Opti-
MEM I, IL-1 (10 ng/mL), IFN- (10 ng/mL), or SEB (0.1 g/
mL) at 37°C and 5% CO2. Migrating cells reaching a line (L2)
situated 240 m from the culture wound after 24 (L2D1) and
48 h (L2D2) were counted using a counting eyepiece with grid
graticule (10  10 mm). The first line of the grids falls together
with the sharp beginning demarcation of the wound. Ten places
were counted in each wound.
Cellular localization of SEB. Cellular localization of SEB
was assayed by immunofluorescence confocal microscopy. Na-
sal tissue fibroblasts were cultured with 0.1 g/mL SEB, with or
without IFN- (10 ng/mL), on poly-D-lysine–coated glass slides
for 24 h at 37°C in 5%CO2. The slideswere then air dried for 24 h
at room temperature and stored at20°C. At the time of stain-
ing they were fixed in acetone for 10 min at 4°C and blocked
using 0.4% fish-skin gelatine/1 PBS for 2 h at room tempera-
ture. The cells were then incubated with rabbit polyclonal anti-
body anti-SEB (1:500; Sigma) for 1 h and with the secondary
antibody anti-rabbit Alexa Fluor 526 (1:2000;Molecular Probes)
for 1 h at room temperature; both primary and secondary anti-
bodies were diluted in 0.4% fish-skin gelatine/1 PBS. After
nuclear staining, 4',6-diamidino-2-phenylindole (DAPI;Molec-
ular Probes) was added for 5 min, and the slides were mounted
in Vectashield mounting medium (Vector Laboratories). Cellu-
lar localization of the enterotoxin was evaluated using a Bio-Rad
Radiance 2100 laser scanning confocalmicroscope systemwith a
4-line argon primary laser, a green helium-neon laser, and a blue
laser diode. Image analysis was performed using Adobe Photo-
shop (version 7.0) and Confocal Assistant (version 4.02, Todd
Clark Brelje) software programs.
Statistical analysis. All data were analyzed using MedCalc
software (version 6.0) and are presented as medians and inter-
quartile ranges. Data were compared within different patient
subgroups by use of the Kruskal-Wallis test (H test). The Wil-
coxon test for unpaired samples (or Mann-Whitney U test) was
applied to evaluate the statistical differences between patient
groups. Our criterion for significance was P  .05.
RESULTS
Effect of SEB on PGE2 production. Nasal tissue fibroblasts
cultured in MEM in the absence of stimulus produced signifi-
cant baseline concentrations of mRNA of COX-2 and PGE2.
Stimulationwith SEBwithout preincubationwith IFN- did not
induce any change in PGE2 production or COX-2 mRNA ex-
pression. Induction of MHC-II molecule expression in fibro-
blasts by stimulation with IFN- was verified by real-time PCR,
demonstrating HLA-DR1 gene expression in all IFN-–stimu-
lated cells compared with nonstimulated cells (figure 1). Fur-
thermore, preincubationwith IFN- led to a significant decrease
Table 1. Primer sequences used for real-time polymerase chain reaction amplification.
Gene
Primer (5'33')
Amplicon
size, bp
GenBank
accession no.Forward Reverse
HLA-DR1 CATCAAGGGAGTGCGCA CTCCATGTGCCTTACAGAGGC 64 NM_019111
COX-2 GCTGGAACATGGAATTACCCA CTTTCTGTACTGCGGGTGGAA 88 XM_051899
EP1 GATGGTGGGCCAGCTTGTC GCCACCAACACCAGCATTG 73 NM_000955
EP2 GACCGCTTACCTGCAGCTGTAC TGAAGTTGCAGGCGAGCA 73 NM_000956
EP3 AAGGCCACGGCATCTCAGT TGATCCCCATAAGCTGAATGG 76 NM_000957
EP4 ACGCCGCCTACTCCTACATG AGAGGACGGTGGCGAGAAT 63 NM_000958
NOTE. COX-2, cyclooxygenase 2; EP1–4, prostanoid E receptors 1–4.
Figure 1. Box-and-whisker plots representing the expression levels of
the HLA-DR gene in nasal tissue fibroblasts before and after incubation
with interferon (IFN)– (10 ng/mL).
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in COX-2 mRNA (figure 2a) and endogenous PGE2 (figure 2b)
compared with nonstimulated cells. Interestingly, this down-
regulation was amplified after incubation with SEB at 0.1 and 1
g/mL in a dose-independent manner. In addition, incubation
with IL-1 significantly increased the expression of COX-2 and
PGE2 release. Furthermore, expression of the transcripts ex-
pressing the genes encoding for prostanoid E receptors (EP1,
EP2, EP3, and EP4) was analyzed. Real-time PCR results showed
no expression of EP4 receptor in nasal fibroblasts (data not
shown). SEB did not induce any change in the expression of EP1
(figure 3a) and EP3 (figure 3c) receptors; however, the entero-
toxin down-regulated the EP2 receptor after preincubation with
IFN-, and this effect was dose dependent (figure 3b).
Effect of SEB on growth and migration. Results of the
growth test were expressed as numbers of living cells after 24, 48,
and 72 h. The number of cells per stimulus was compared with
the number of cells cultured only in MEM, which were consid-
ered to be controls for normal growth. Cells in MEM showed a
significant increase in proliferation after 72 h. The same pattern
was observed in cells stimulated with IFN- or IL-1 (figure 4).
When cells were incubated with SEB, however, cell proliferation
was inhibited. This process was IFN- independent and was
counterbalanced by coexposurewith the cytokine. Furthermore,
the cell migration capacity was not changed by incubation with
IFN- or SEB. After preincubation with IFN-, however, SEB
significantly induced this process (figure 5).
Cellular localization of SEB. Cellular localization of SEB
was assayed by confocal microscopy. Confocal images of nasal
fibroblasts after incubation with 0.1g/mL SEB for 24 h showed
that the enterotoxinwas locatedmainly in the cytoplasmbut also
partly in the nucleus of the cell (figure 6c and 6d), indicating
spontaneous penetration into the cell. A different distribution
was observed after preincubation with IFN- followed by stim-
ulation with 0.1 g/mL SEB (figure 6e and 6f). The enterotoxin
was located mainly in the periphery of the cell cytoplasm and
around the nucleus, suggesting the binding of SEB to MHC-II
molecules on the cell surface.
DISCUSSION
Eicosanoid production is differentially regulated and correlates
with the degree of inflammation in patients with nasal polyps
with and without an immune response (specific IgE antibodies)
to S. aureus enterotoxins [9]. PGE2 plays an important role in the
regulation of tissue repair events during airway diseases, and this
mechanismmay be influenced by triggers such as viral or bacte-
rial infections. Therefore, we aimed to investigate whether
staphylococcal enterotoxinsmay affect the upper airway remod-
eling process and influence the eicosanoid pathway of nasal tis-
sue fibroblasts.
In this study, we were able to demonstrate that the levels of
endogenous PGE2, COX-2 mRNA, and EP2 receptor signifi-
cantly decreased after stimulationwith SEB in IFN-–pretreated
cells but not in cells cultured without the cytokine, suggesting
that this effect may be mediated by cross-linking with the
MHC-II receptor. Incubation with IFN- was performed to in-
duce the MHC-II molecules, which are normally not expressed
in fibroblasts, and mimic the classic binding of superantigens to
the cell. This cytokine has been demonstrated to induce the syn-
Figure 2. mRNA levels of cyclooxygenase (COX)–2 (a) and concentra-
tions of prostaglandin E2 (PGE2) (b) in nasal tissue fibroblasts after
stimulation with interleukin (IL)–1 (10 ng/mL), interferon (IFN)– (10
ng/mL), or Staphylococcus aureus enterotoxin B (SEB; 0.01, 0.1 or 1
g/mL). *Significant difference compared with cells incubated with
minimum essential medium (MEM); §significant difference compared with
cells stimulated with IFN- (10 ng/mL) (P 	 .05, Mann-Whitney U test
for independent samples).
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thesis and activation of cytosolic phospholipase A2 (cPLA2) pro-
tein in a human bronchial epithelial cell line [15]. However, it
seems that nasal fibroblastsmay react differently to the cytokine,
because COX-2 and PGE2 were significantly down-regulated
compared with nonstimulated cells. Additionally, staphylococ-
cal enterotoxins have been demonstrated to induce PGE2 pro-
duction and COX-2 and cPLA2 expression in IFN-–treated fi-
broblastlike synoviocytes [10]. However, in nasal fibroblasts,
SEB acted as an agonist of the cytokine by accentuating the
blockage of the COX pathway.
There have been no previous studies showing the effect of
superantigens on PGE2 release in nasal fibroblasts. However,
Clement et al. have demonstrated highly focalized intracellu-
lar reservoirs of S. aureus (including the nasal epithelium,
glandular tissue, and myofibroblasts) in endonasal mucosa
from patients with recurrent S. aureus rhinosinusitis [16].
These findings support our thinking that the presence of SEB
in nasal tissue may exacerbate airway inflammation by down-
regulating the production of anti-inflammatory mediators,
such as PGE2.
Moreover, staphylococcal superantigens may act as potent
leukocyte and neutrophil chemoattractants [17]. In support of
these findings, we have found that SEB significantly induced fi-
broblastmigration. This effect seems to bemediated by the bind-
ing ofMHC-II, because no effect was observed in the presence of
the enterotoxin or IFN- alone. IFN- has been reported to in-
crease the expression of both intercellular adhesion molecule 1
and vascular cell adhesion molecule in human lung fibroblasts
[18], important regulators of cell adhesion and migration pro-
cesses. Furthermore, it has been shown that SEB can induce T
cell adhesion to endothelial cells (pretreated with IFN-) in an
MHC-II–dependent mechanism [19], which may confirm the
findings of this study. However, although it was not our current
objective, it may be useful to evaluate the expression of cell mi-
gration–related molecules to learn more about the mechanisms
modulating this process.
SEB blocked proliferation in the cell culture when it was ap-
plied in the absence of IFN-, and this effect may be restored by
the cytokine. Although the effect of SEB on cell proliferation is
unknown, the superantigen may block this process by cross-
linking receptors other than MHC-II or simply by altering cell
membrane permeability or activating molecules that regulate
this cell function. Furthermore, PGE2 has been reported as an
important inhibitor of fibroblast proliferation and migration
[20, 21]. However, analyzing our results, we suggest that the
effect of SEB on fibroblast proliferation is not linked to PGE2
regulation. On the contrary, the migration process seems to be
influenced by the decrease in eicosanoid levels after SEB expo-
sure. However, this can be confirmed only by performing exper-
iments in the presence of PGE2 and MHC-II antagonists, which
should be the aim of further studies.
Figure 3. mRNA levels of prostanoid E (EP) receptors EP1 (a), EP2 (b),
and EP3 (c) in nasal tissue fibroblasts after stimulation with interleukin
(IL)–1 (10 ng/mL), interferon (IFN)– (10 ng/mL), or Staphylococcus
aureus enterotoxin B (SEB; 0.01, 0.1, or 1 g/mL). *Significant difference
compared with cells incubated with minimum essential medium (MEM);
§significant difference compared with cells stimulated with IFN- (10
ng/mL) (P 	 .05, Mann-Whitney U test for independent samples).
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Finally, confocal microscopy showed the presence of SEB
within cells with and without MHC-II receptors. These find-
ings suggest that the enterotoxin may enter the cell via alter-
nate mechanisms or receptors in cells that lack MHC-II or
T cell receptors. Studies have shown that SEB may cross
the epithelium by facilitated transcytosis [22], and the
existence of alternative binding site proteins has been also
reported in monkey kidney fibroblasts [23]. Our results indi-
cate that the effect of SEB on human nasal fibroblast metab-
olism may depend on how the molecules enter the cell and
may or may not depend on the classic superantigen-binding
mechanism.
Figure 4. Growth curve for nasal tissue fibroblasts showing the number of proliferated cells after incubation with interleukin (IL)–1 (10 ng/mL),
interferon (IFN)– (10 ng/mL), or Staphylococcus aureus enterotoxin B (SEB; 0.1 g/mL) for 24, 48, and 72 h. P values were determined by the
Mann-Whitney U test for independent samples. N.S., not significant.
Figure 5. Migration test for nasal tissue fibroblasts after stimulation with interleukin (IL)–1 (10 ng/mL), interferon (IFN)– (10 ng/mL), or
Staphylococcus aureus enterotoxin B (SEB; 0.1 g/mL). Graph shows the number of cells migrating 240 m from the wound site after 24 h (L2D1) and
48 h (L2D2). MEM, minimum essential medium.
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In conclusion, SEB may down-regulate COX-2 gene expres-
sion and PGE2 production in human nasal tissue fibroblasts, and
this action seems to involve EP2 but not EP1, EP3, or EP4 recep-
tors. Additionally, this enterotoxin may affect important ba-
sic cell functions, such as growth andmigration. Determining
themechanism behind this action was not the objective of this
study, but it seems that mechanisms other than the conven-
tional binding via MHC-II allow the enterotoxin to enter the
cell and influence its metabolism. The present study will be
followed by experiments using PGE2 and MHC-II inhibitors,
which can provide more information on the regulatory mech-
anisms acting on these cells. Triggering of the arachidonic
acid metabolism is one of the cellular events regulating the
pro- and anti-inflammatory immune response in diseases.
The findings of this study may have major implications for
our understanding of the role played by bacterial superanti-
Figure 6. Confocal microscopic images (original magnification, 40) of nasal tissue fibroblasts incubated with minimum essential medium (a and
b), stimulated with Staphylococcus aureus enterotoxin B (SEB; 0.1 g/mL) for 24 h (c and d ), or preincubated with interferon- (10 ng/mL) and stimulated
with SEB (0.1 g/mL) for 24 h (e and f ). Images show that SEB is internalized in the nasal fibroblasts and can be localized in the cytoplasm and in
the nucleus of the cell.
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gens in regulating the inflammatory and remodeling mecha-
nisms of upper airway diseases and, hence, help to elucidate
their pathophysiology.
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